Download5
Stock
File Size1.66 MB
Create DateMarch 18, 2016
Download

Lee, D., E. Kim, and B. Santoso.

Abstract:

SIAPS conducted a review of regulatory and quality assurance efforts in the GMS with the following objectives

  • To inform PMI of past and current initiatives to improve the capacity of the region to combat counterfeit, substandard, and banned antimalarial medicines
  • To understand the current barriers to effective medicine quality control for malaria
  • To recommend specific areas of focus or interventions to further improve regional and country capacity to combat counterfeit, substandard, and banned or illegal antimalarial medicines